MapLight Therapeutics, Inc. (MPLT)
MapLight Therapeutics, Inc. (MPLT) Insider Trading
Directors, officers and holders of more than 10% of MPLT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 225 transactions on file: 1 with code P, 35 with code S and 14 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 10,167 | $8.08 | $82,149 |
| Oct 15, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 15,355 | $8.08 | $124,068 |
| Oct 15, 2026 | Hanson Kristopher | General Counsel | S Sale | 9,020 | $8.08 | $72,882 |
| Oct 15, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 12,248 | $7.84 | $96,024 |
| Oct 15, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 11,513 | $8.08 | $93,025 |
| Oct 15, 2026 | Kroeger Christopher A. | Chief Executive Officer | S Sale | 73,691 | $8.08 | $595,423 |
| Sep 16, 2026 | Hanson Kristopher | General Counsel | S Sale | 16,509 | $11.67 | $192,660 |
| Aug 17, 2026 | Kroeger Christopher A. | Chief Executive Officer | A Award | 23,145 | Not measured | Not measured |
| Aug 17, 2026 | Hanson Kristopher | General Counsel | A Award | 31,395 | Not measured | Not measured |
| Aug 17, 2026 | Lillie James Woodruff | Chief Scientific Officer | A Award | 31,395 | Not measured | Not measured |
| Aug 17, 2026 | Foff Erin Pennock | Chief Medical Officer | A Award | 54,240 | Not measured | Not measured |
| Aug 17, 2026 | Hanson Kristopher | General Counsel | A Award | 7,730 | Not measured | Not measured |
| Aug 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | A Award | 24,455 | Not measured | Not measured |
| Aug 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | A Award | 2,813 | Not measured | Not measured |
| Aug 17, 2026 | Foff Erin Pennock | Chief Medical Officer | A Award | 13,360 | Not measured | Not measured |
| Aug 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | A Award | 24,455 | Not measured | Not measured |
| Aug 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | A Award | 2,222 | Not measured | Not measured |
| Aug 17, 2026 | Lillie James Woodruff | Chief Scientific Officer | A Award | 7,730 | Not measured | Not measured |
| Aug 17, 2026 | Kroeger Christopher A. | Chief Executive Officer | A Award | 93,955 | Not measured | Not measured |
| Aug 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | A Award | 6,020 | Not measured | Not measured |
| Aug 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | A Award | 6,020 | Not measured | Not measured |
| Aug 3, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 22,082 | $12.54 | $276,908 |
| Jul 28, 2026 | Cox Troy | Director | P Purchase | 15,620 | $9.52 | $148,702 |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 900 | $38.17 | $34,353 |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 16,969 | $37.61 | $638,204 |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 600 | $36.51 | $21,906 |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 2,833 | $37.05 | $104,963 |
| Jul 17, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 2,077 | $37.90 | $78,718 |
| Jul 17, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 3,656 | $37.90 | $138,562 |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 14,140 | $37.70 | $533,078 |
| Jul 17, 2026 | Kroeger Christopher A. | Chief Executive Officer | S Sale | 16,779 | $37.90 | $635,924 |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 200 | $38.39 | $7,678 |
| Jul 17, 2026 | Hanson Kristopher | General Counsel | S Sale | 1,130 | $37.90 | $42,827 |
| Jul 16, 2026 | Hanson Kristopher | General Counsel | S Sale | 11 | $37.96 | $418 |
| Jul 16, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 1,476 | $37.44 | $55,261 |
| Jul 16, 2026 | GILLIS JONATHAN | CAO and Interim CFO | S Sale | 6,979 | $36.66 | $255,850 |
| Jul 16, 2026 | Hanson Kristopher | General Counsel | S Sale | 3,331 | $37.26 | $124,113 |
| Jul 16, 2026 | Kroeger Christopher A. | Chief Executive Officer | S Sale | 40,899 | $36.46 | $1,491,178 |
| Jul 16, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 7,464 | $36.66 | $273,630 |
| Jul 16, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 19 | $37.96 | $721 |
| Jul 16, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 12 | $37.96 | $456 |
| Jul 16, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 5,009 | $36.45 | $182,578 |
| Jul 16, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 5,865 | $37.26 | $218,530 |
| Jul 16, 2026 | Lillie James Woodruff | Chief Scientific Officer | S Sale | 3,526 | $37.26 | $131,379 |
| Jul 16, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 9,163 | $36.46 | $334,083 |
| Jul 16, 2026 | Kroeger Christopher A. | Chief Executive Officer | S Sale | 92 | $37.96 | $3,492 |
| Jul 16, 2026 | Kreitzer Anatol | Chief Discovery Officer | S Sale | 1,592 | $37.44 | $59,604 |
| Jul 16, 2026 | Hanson Kristopher | General Counsel | S Sale | 4,776 | $36.45 | $174,085 |
| Jul 16, 2026 | Kroeger Christopher A. | Chief Executive Officer | S Sale | 28,091 | $37.26 | $1,046,671 |
| Jul 15, 2026 | Foff Erin Pennock | Chief Medical Officer | S Sale | 7,845 | $37.04 | $290,579 |
The full Form 4 history is on the MPLT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.